Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations
Robert W. Holloway(Florida Hospital Cancer Institute), Rebecca J. Wolsky(University of Colorado Anschutz Medical Campus), Floor Backes(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Walter H. Gotlieb(McGill University), John F. Boggess(University of Kentucky), Edward J. Tanner(Johns Hopkins Hospital), Emma Rossi(Indiana University – Purdue University Indianapolis), William J. Lowery(Walter Reed National Military Medical Center), Nadeem R. Abu‐Rustum(Memorial Sloan Kettering Cancer Center)
Cited by 409
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
|American Journal of Obstetrics and Gynecology|2008|458